Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001658021-22-000001
Filing Date
2022-11-10
Accepted
2022-11-10 14:47:10
Documents
1
Effectiveness Date
2022-11-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8456
  Complete submission text file 0001658021-22-000001.txt   9512
Mailing Address 67 SOUTH BEDFORD STREET, SUITE 400W BURLINGTON MA 01803
Business Address 67 SOUTH BEDFORD STREET, SUITE 400W BURLINGTON MA 01803 617-468-4646
General Oncology, Inc. (Filer) CIK: 0001658021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-343809 | Film No.: 221376553